In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 24th, 2004 | 28 | Yes |
Popular Name: Terazosin hydrochloride Terazosin hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 63074-08-8 , 63074-08-8; 63590-64-7; 70024-40-7 , 63590-64-7 , 70024-40-7 , [70024-40-7]
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride
6,7-bis(methyloxy)-2-[4-(tetrahydrofuran-2-ylcarbonyl)piperazin-1-yl]quinazolin-4-amine
6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine
6,7-dimethoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride
6,7-dimethoxy-2-[4-(tetrahydrofuran-2-ylcarbonyl)piperazin-1-yl]quinazolin-4-amine
63590-64-7; Prestwick_146; Terazosin hydrochloride
70024-40-7 (mono-hydrochloride, dihydrate)
CPD000058309; SAM002589982; Terazosin
INN); Terazosin Hydrochloride (FDA
Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-
Terazosin monohydrochloride dihydrate
Terazosin hydrochloride anhydrous
Terazosin Hydrochloride dihydrate
Terazosin monohydrochloride dihydrate
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](tetrahydrofuran-2-yl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.31 | 7.78 | -39.71 | 3 | 9 | 1 | 104 | 388.448 | 4 | ↓ |
Hi High (pH 8-9.5) | 1.31 | 7.48 | -19.52 | 2 | 9 | 0 | 103 | 387.44 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 99% | APIChem |
Indications | antihypertensive | KeyOrganics Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : T-8046; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE TO WHITE WITH A YELLOW CAST POWDER | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: T-8046; SUPPLIER_COMMENTS: WHITE TO WHITE WITH A YELLOW CAST POWDER | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A-1-E | Alpha-1a Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4 | 0.42 | Binding ≤ 10μM |
ADA1B-1-E | Alpha-1b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 30 | 0.38 | Binding ≤ 10μM |
ADA1D-1-E | Alpha-1d Adrenergic Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4 | 0.42 | Binding ≤ 10μM |
ADA2A-1-E | Alpha-2a Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 550 | 0.31 | Binding ≤ 10μM |
ADA2B-1-E | Alpha-2b Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 8 | 0.40 | Binding ≤ 10μM |
ADA2C-1-E | Alpha-2c Adrenergic Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 78 | 0.36 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 26 | 0.38 | Binding ≤ 1μM |
ADA1A_RAT | P43140 | Alpha-1a Adrenergic Receptor, Rat | 0.82 | 0.45 | Binding ≤ 1μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 2 | 0.43 | Binding ≤ 1μM |
ADA1B_RAT | P15823 | Alpha-1b Adrenergic Receptor, Rat | 1.9 | 0.44 | Binding ≤ 1μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 0.69 | 0.46 | Binding ≤ 1μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 0.85 | 0.45 | Binding ≤ 1μM |
ADA1D_RAT | P23944 | Alpha-1d Adrenergic Receptor, Rat | 1.01 | 0.45 | Binding ≤ 1μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 550 | 0.31 | Binding ≤ 1μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 7.7 | 0.41 | Binding ≤ 1μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 26 | 0.38 | Binding ≤ 1μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 170 | 0.34 | Binding ≤ 1μM |
ADA1A_HUMAN | P35348 | Alpha-1a Adrenergic Receptor, Human | 2 | 0.43 | Binding ≤ 10μM |
ADA1A_BOVIN | P18130 | Alpha-1a Adrenergic Receptor, Bovin | 26 | 0.38 | Binding ≤ 10μM |
ADA1A_RAT | P43140 | Alpha-1a Adrenergic Receptor, Rat | 0.82 | 0.45 | Binding ≤ 10μM |
ADA1B_RAT | P15823 | Alpha-1b Adrenergic Receptor, Rat | 1.9 | 0.44 | Binding ≤ 10μM |
ADA1B_HUMAN | P35368 | Alpha-1b Adrenergic Receptor, Human | 0.69 | 0.46 | Binding ≤ 10μM |
ADA1D_HUMAN | P25100 | Alpha-1d Adrenergic Receptor, Human | 0.85 | 0.45 | Binding ≤ 10μM |
ADA1D_RAT | P23944 | Alpha-1d Adrenergic Receptor, Rat | 1.01 | 0.45 | Binding ≤ 10μM |
ADA2A_HUMAN | P08913 | Alpha-2a Adrenergic Receptor, Human | 1500 | 0.29 | Binding ≤ 10μM |
ADA2B_RAT | P19328 | Alpha-2b Adrenergic Receptor, Rat | 7.7 | 0.41 | Binding ≤ 10μM |
ADA2B_HUMAN | P18089 | Alpha-2b Adrenergic Receptor, Human | 26 | 0.38 | Binding ≤ 10μM |
ADA2C_HUMAN | P18825 | Alpha-2c Adrenergic Receptor, Human | 170 | 0.34 | Binding ≤ 10μM |
Description | Species |
---|---|
Adrenaline signalling through Alpha-2 adrenergic receptor | |
Adrenaline,noradrenaline inhibits insulin secretion | |
Adrenoceptors | |
G alpha (12/13) signalling events | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (z) signalling events |